Novartis AG NVS NYSE

Novartis AG (NVS) generated $2.25B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $610.9M, free cash flow was $1.64B.

Free cash flow margin was 12.3% of revenue. Cash conversion ratio was 0.94x, suggesting some earnings are non-cash.

The company returned $1.48B in share buybacks to shareholders during the quarter.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (94/100, Pass) — $1.64B (12.3% margin) supports a durable competitive advantage
• INCOME (85/100) — Cash conversion ratio was 0.94x suggests some earnings are non-cash items

Overall SharesGrow Score: 68/100 with 4/7 criteria passed.